Ventyx Biosciences (VTYX) Institutional Ownership

97.88% of Ventyx Biosciences' stock is owned by institutional investors. Learn more on VTYX's institutional investor holdings.

Of the 114 institutional investors that purchased Ventyx Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Affinity Asset Advisors LLC ($7.10M), Bank of America Corp DE ($3.38M), Marshall Wace LLP ($2.40M), Baker BROS. Advisors LP ($2.35M), Deerfield Management Company L.P. Series C ($2.29M), Braidwell LP ($1.92M), and Point72 Asset Management L.P. ($1.78M).

Institutional investors have bought a total of 25,986,088 shares in the last 24 months. This purchase volume represents approximately $150.85M in transactions.

Of the 40 institutional investors that sold Ventyx Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Sio Capital Management LLC ($1.27M), Sectoral Asset Management Inc. ($1.01M), Goldman Sachs Group Inc. ($917.51K), Monaco Asset Management SAM ($908.84K), Geode Capital Management LLC ($757.62K), Millennium Management LLC ($661.88K), and JPMorgan Chase & Co. ($586.22K).

Institutional investors have sold a total of 10,076,559 shares in the last 24 months. This volume of shares sold represents approximately $46.90M in transactions.